Research Interest: Structural determination of protein-DNA, Solid: X-ray, Solution: 2D & 3D NMR, and Gas: Mass Spectrometry, interactions and their pathways, stability, dynamics, and function.

•    Postdoctoral Research Fellow, University of Botswana, Gaborone, August 2021-Present

•    Senior Consultant (Covid-19), Botswana Harvard AIDS Partnership, Gaborone, March 2020-Present

•    Mentor/Advisory (Undergraduate Students), University of Botswana, Gaborone, January 2017-Present

•    Research Laboratory Scientist, Botswana-UPenn Partnership, Gaborone, February 2015- July 2021

•    Intern, UCSI University, Kuala Lumpur, January 2013- July 2013

•    Research Laboratory Assistant, UCSI University, Kuala Lumpur, October 2012- December 2013

Research Interest:  Pharmacokinetics/genomics in HIV and Malaria, HIV infection on the distribution of human papillomavirus genotypes, Pathogenesis of persistent cervicovaginal infections of oncogenic HPV genotypes, Host epigenetic changes associated with cervical cancer progression, Clinical trials work to improve meningitis outcomes in Botswana, Examining the utility of novel diagnostics to improve outcomes in HIV-associated meningitis patients, Molecular Surveillance of Plasmodium falciparum Drug Resistance Markers and Plasmodium falciparum multi drug resistance gene 1 mutations in symptomatic patients.

Grants: Identification of differential expression of host genes in cervical cancer, U54-, U54, Co-PI and Graduate Student, 05/24/17-05/28/21 and Human papillomavirus infection in HIV-infected and HIV-uninfected women from Botswana and Kenya: HPV genetic variation by phylogenetic type. Project Leader, 2019 to 2021.

Research Interest: Immunology, veterinary immunology, lymphocytes, innate immunity, receptors, viral infections, RNA viruses.

Research Interest: Pre-treatment staging of lung cancer using integrated CT-PET and comparing its accuracy with conventional CT scan and pathological staging. Prospective study on the incidence of post-needle biopsy pneumothorax looking  at the relationship between early lung function testing  manoeuvre, after full radiological expansion of lung and recurrence of pneumothorax. UP-FRONT FDG CT-PET study - Prospective study to look at whether performing Up-Front FDG CT-PET in the pre-treatment evaluation of lung cancer reduces time interval and the number of invasive procedures for definitive diagnosis.

Research Interest: Vaccine, innate immunity, parasite-host interaction.

Research Interest: Infectious disease, vaccine, immunology, focus in infectious diseases, epidemiology, microbiology, vaccine development and efficacy.

Research Interest: Biotechnology, Vaccines, Vaccine Development, Virology, Viral Vaccines.

Research Interest: Infectious diseases in animals, diagnostics, epidemiology, efficiency of vaccination programmes.

Research Interest: Conduct several molecular biology and genomic assays including Sequencing, Cloning, RT-PCR, Southern blot, Northern blot, and Immunostaining.

Research Interest: Oncology, Immunology and Hematopoiesis.

I am a Postdoctoral Research Scientist at the Columbia University Irving Medical Center where I am understanding the mechanism of AICDA, a DNA mutator with paramount importance in antibody diversity in on target activity using human Bcells. I am studying this by targeted degradation of essential proteins using a state of art technology called Degron system which are generated using knockin and single cell cloning. These targets were identified from mass spec and mutations seen in DHL and DLBCL a form of Bcell lymphoma.

During my Ph.D I delineated interaction between CD40L- CD40 during a macrophages T cell interaction using residue specific functions on CD40L which are reported in hyper IgM syndrome. While studying this I also generated avirulent strains of Leishmania parasites which we testes as a vaccine strain in different knockout mice and studied the immune response elicited by this vaccine. I also developed a DNA vaccine against one of the target proteins in the Leishmania and testes it. During my master's in Virology from the National Institute of Virology, Pune I study different classes of virus and their pathogenesis. In particular, I studied the role of host kinases in the pathogenesis of the Japanese Encephalitis virus for my master's dissertation. I have a deep understanding of Immunology, APC-Tcell interaction, host-pathogen interactions, RNA biology, Bcell biology and vaccines. My area of interest is immunology, tumor immunology, macrophages, Bcells, host-pathogen interactions, virology, RNA biology, and cancer biology.

Research Interest: Lymphoma, Bcell biology, receptor-ligand interaction, host-pathogen-interaction, macrophages and tumor immunity

Research Interest: Cytokine based Immunotherapies to treat lymphopenia, Clinical biomarkers in psychological disorders, Effects of Inflammation on hematopoiesis.

David A. Reardon, MD, is a Professor of Medicine at Harvard Medical School and currently serves as Clinical Director of the Center for Neuro-Oncology at the Dana-Farber Cancer Institute.

He previously served as the Associate Deputy Director of the Preston Robert Tisch Brain Tumor Center at Duke University Medical Center for eleven years. He completed his residency at John Hopkins Hospital in Maryland, USA and was awarded a fellowship at the University of Michigan. Dr. Reardon is an active researcher with special interests in the design and implementation of clinical trials for neuro-oncology and the preclinical evaluation of promising therapeutics for central nervous system tumors.

His work includes using innovative clinical therapeutic agents to improve outcome for patients with brain and spinal tumors, with particular focus on immunotherapeutics. He has also led investigations of molecular-targeting agents, anti-angiogenic reagents, cytotoxins and other biologically-based therapies.

Dr. Reardon has published over 290 peer-reviewed manuscripts. He received the R. Wayne Rundles Award for Excellence in Cancer Research as well as the Award for Excellence in Adult Clinical Research by the Society for Neuro-Oncology in 2015 and 2016. He also served as the tenth president of the Society for Neuro-Oncology from 2013-2015.

Research Interest: Innovative Clinical Therapeutic Agents To Improve Cure Rates In Patients With Brain And Spinal Tumors, With Particular Focus On Immunotherapeutics As Well As Molecular-Targeting Agents, Anti-Angiogenic Reagents, Cytotoxins And Other Biologically-Based Therapies.

Research Interest: The keywords of my research interest: Reproductive immunology, Thymic stromal lymphopoietin, The costimulatory signal, Trophoblast, Gamma-delta T cell, CD4+CD25bright regulatory T cell, Pregnancy, Miscarriage, The maternal-fetal immune.